Pectoral Fascial Plane and Serratus Anterior Plane Blocks With Bupivacaine v. Liposomal Bupivacaine
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Patients will be randomized the day of surgery upon presentation to the operating room to
either a treatment group (PECSII/SAP blocks with bupivacaine HCl plus liposomal bupivacaine)
or a control group (PECSII/SAP blocks with bupivacaine HCl plus preservative free normal
saline) using secure web-based randomization. Assignments will be based on computer-generated
code. Clinicians will not be blinded to the intervention, but all outcomes will be assessed
by research personnel who are blinded to the group assignment.